Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate-Reference-Cited by-同舟云学术

Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate

Published:2018-09 Issue: Volume:79 Page:151-159
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Xin Zhixiang,Zhang Yong,Jiang Zhou,Zhao Ling,Fan Liancheng,Wang Yanqing,Xie Shaowei,Shangguan Xun,Zhu Yinjie,Pan Jiahua,Liu Qiang,Huang Yiran,Dong Baijun,Xue Wei

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference36 articles.

1. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives;Helpap;Urol Int,1999

2. Brain metastasis from prostate small cell carcinoma: not to be neglected;Erasmus;Can J Neurol Sci,2002

3. Targeting neuroendocrine prostate cancer: molecular and clinical perspectives;Vlachostergios;Front Oncol,2015

4. Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy;Miyoshi;BJU Int,2001

5. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications;Theodoropoulos;Urology,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INSM1 is a useful neuroendocrine marker to differentiate pancreatic serous cystadenoma from pancreatic well-differentiated neuroendocrine tumors in cytology and surgical specimens;Annals of Diagnostic Pathology;2024-08

2. Immunotherapy for small cell carcinoma of the prostate: A new treatment frontier;Asian Journal of Surgery;2024-07

3. Molecular Pathology of Prostate Cancer;Clinics in Laboratory Medicine;2024-06

4. Prognostic nomogram to predict cancer-specific survival with small-cell carcinoma of the prostate: a multi-institutional study;Frontiers in Oncology;2024-05-10

5. Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer;Cells;2024-04-12